Frequency of Use, Awareness, and Attitudes Toward Side Effects of Anabolic–Androgenic Steroids Consumption Among Male Medical Students in Iran

REFERENCES

• Allahverdipour, H., Jalilian, F., & Shaghaghi, A. (2012). Vulnerability and the intention to anabolic steroids use among Iranian gym users: An application of the theory of planned behavior. Substance Use & Misuse, 47(3), 309–317.
   PubMed Web of Science ®Google Scholar
• Brower, K. J. (2009). Anabolic steroid abuse and dependence in clinical practice. Physician and Sports Medicine, 37(4), 131–140.
   PubMed Web of Science ®Google Scholar
• Caraci, F., Pistarà, V., Corsaro, A., Tomasello, F., Giuffrida, M. L., Sortino, M. A., (2011). Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. Journal of Neuroscience Research, 89(4), 592–600.
   Google Scholar
• Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 11, 4:12.
   Google Scholar
• Costine, B. A., Oberlander, J. G., Davis, M. C., Penatti, C. A., Porter, D. M., Leaton, R. N., (2010). Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse. Psychoneuroendocrinology, 35(10), 1473–85.
   Google Scholar
• Eisenberg, E. R., & Galloway, G. P.. Anabolic-androgenic steroids. In: J. H. Lowinson, P. Ruiz, R. B. Mill man, J. G. Long lord. Substance abuse. (4th edn, pp. 421–447). Philadelphia: Lippincott Williams & Wilkins; 2005.
   Google Scholar
• Fitch, K. D. (2008). Androgenic-anabolic steroids and the Olympic games. Asian Journal of Andrology, 10(3), 384–390.
   Google Scholar
• Goldberg, L, Elliot, D, Clarke, G. N., MacKinnon, D. P., Moe, E, Zoref, L, Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA: The Journal of the American Medical Association, 276(19), 1555–1562.
   Google Scholar
• Hakansson, A, Mickelsson, K, Wallin, C, & Berglund, M. (2012). Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. European Addiction Research, 18(2), 83–90. Epub 2012 Jan 28.
   PubMed Web of Science ®Google Scholar
• Hazave, M. M., & Abdol-maleki, M. H. (2000). Review the status of anabolic steroid abuse among bodybuilders athletes in 1376 in Hamadan. Journal of University of Medical Sciences, 6(2), 31–8.
   Google Scholar
• Hildebrandt, T, Schlundt, D, Langenbucher, J, & Chung, T. (2006). Presence of muscle dysmorphia symptomology among male weightlifters. Comprehensive Psychiatry, 47(2), 127–135.
   PubMed Web of Science ®Google Scholar
• Hildebrandt, T., Yehuda, R, & Alfano, L. (2011). What can allostasis tell us about anabolic-androgenic steroid addiction?. Development and Psychopathology, 23(3), 907–919.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Brower, K. J., Wood, R. I., Hudson, J. I., & Harrison, G. P., Jr. (2009). Anabolic-androgenic steroid dependence: An emerging disorder. Addiction, 104(12), 1966–1978.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Hudson, J. I., & Harrison, G. P. Jr. (2009). Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug and Alcohol Dependence, 102(1–3), 130–137.
   PubMed Web of Science ®Google Scholar
• KanayamaG., Hudson, J. I., & Harrison, G. P. Jr. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse. A looming public health concern?. Drug and Alcohol Dependence, 98(1–2), 1–12.
   PubMed Web of Science ®Google Scholar
• Kanayama, G, Pope, H. G. Jr, & Hudson, J. I. (2001). “Body image” drugs: A growing psychosomatic problem. Psychotherapy and Psychosomatics, 70(2), 61–65.
   Google Scholar
• Kargarfard, A., Kasha, A., & Sarlak, Z. (2009). Prevalence of ergogenic substances use and athletes’ knowledge of effects and side effects of them in Lorestan province, western part of Iran. JFMH, 11(2), 123–134.
   Google Scholar
• Kargarfard, M., Ghias, M., Karimzadegan, A. R., & Kashi, A. (2006). Assumption of anabolic steroids among Isfahan university students: prevalence and awareness about side effects. The Quarterly Journal of Fundamental of Mental Health Autumn and Winter, 8(32,32), 73–80.
   Google Scholar
• Kohtz, A. S., & Frye, C. A. (2012). Dissociating behavioral, autonomic, and neuroendocrine effects of androgen steroids in animal models. Methods in Molecular Biology, 397–431.
   Google Scholar
• Kokkevi, A., Fotiou, A., Chileva, A., Nociar, A., & Miller, P. (2008). Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Substance Use & Misuse, 43(14), 2053–2065.
   PubMed Web of Science ®Google Scholar
• Lumia, A. R., & McGinnis, M. Y. (2010). Impact of anabolic androgenic steroids on adolescent males. Physiology & Behavior, 100(3), 199–204.
   PubMedGoogle Scholar
• Miller, K. E., Hoffman, J. H., Barnes, G. M., Sabo, D, Melnick, M. J., & Farrell, M. P. (2005). Adolescent anabolic steroid use, gender, physical activity and other problem behaviors. Substance Use & Misuse, 40(11), 1637–1657.
   PubMed Web of Science ®Google Scholar
• Nilsson, S., Allebeck, P., Marklund, B., Baigi, A., & Fridlund, B. (2004). Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents. Health Promotion International, 19(1), 61–67.
   PubMedGoogle Scholar
• Nilsson, S., Spak, F., Marklund, B., Baigi, A., & Allebeck, P. (2005). Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescent in a aounty of Sweden. Subset Use Misuse, 40(1), 1–12.
   PubMed Web of Science ®Google Scholar
• Nojoumi, M, & Behravan, V. (2005). Study of anabolic steroid and the awareness of their complications in bodybuilding athletes in Karaj (2003). Razi Journal of Medical Sciences (Journal of Iran University of Medical Sciences), 11(44 special issue 2), 1057–1063.
   Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: a survey of 500 users. Journal of Science and Medicine in Sport, 38(4), 644–651.
   Google Scholar
• Pope, H. G., & Brower, K. J. (2009). Anabolic-androgenic steroid-related disorders. In: Sadock, B., Sadock, V, editors. Comprehensive textbook of psychiatry. 9th edition. Philadelphia, PA: Lippincott Williams & Wilkins; P. 1419–1431.
   Google Scholar
• Rachon, D., Pokrywka, L., & Suchecka-Rachon, K. (2006). Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed, 51(6), 392–398.
   PubMedGoogle Scholar
• Sadock, B. J., & Sadock, V. A.. Synopsis of psychiatry behavioral sciences/clinical psychiatry. 10th ed. Philadelphia: Wolters Kluwer Health, Lippincott Williams & Wilkins; 2007.P.461–3.
   Google Scholar
• Santos, A. M., da Rocha, M. S., & da Silva, M. F. (2011). Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Substance Use & Misuse, 46(6), 742–748.
   PubMed Web of Science ®Google Scholar
• Scott Munby, J. (2010). Drugs in Sports. Medical Journal, 55(2), 29–30.
   Google Scholar
• Sepehri, Gh., & Moosavifar, M. (2003). The frequency of anabolic steroid abuse in body builder athletes in Kerman city. Journal of Rafsanjan University of Medical Sciences and Health Services, 2(3–4), 213–221.
   Google Scholar
• Sjoqvist, F., Garle, M., & Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society. Lancet, 371(9627), 1872–1882.
   PubMed Web of Science ®Google Scholar
• Tavousi, M., Heidarnia, A., Montazeri, A., Taremian, F., Akbari, H., & Haeri, A. (2009). Distinction between two control constructs: An application of the theory of planned behavior for substance abuse avoidance in adolescents. Future of Sciences, 15(4), 36–44.
   Google Scholar
• Thiblin, I., & Peterson, A. (2005). Pharmacoepidemiology of anabolic androgenic steroid a review. Fundamental & Clinical Pharmacology, 19(1), 27–44.
   PubMed Web of Science ®Google Scholar
• Wanjek, B., Rosendahl, J., Strauss, B., & Gabriel, H. H. (2007). Doping, drugs and drug abuse among adolescents in the state of Thuringia (Germany): prevalence, knowledge and attitudes. International Journal of Sports Medicine, 28(4), 346–353.
   PubMed Web of Science ®Google Scholar
• Woerdeman, J., de Hon, O., Levi, M., & de Ronde, W. P. (2010). Anabolic androgenic steroids in amateur sports in the Netherlands. Nederlands Tijdschrift voor Geneeskunde, 154, A2004.
   PubMedGoogle Scholar